Pavani Sayana, MD, is affiliated with the University of Alabama in Huntsville, Alabama. Sayana has published research on addiction, genetics, and neurology, focusing on topics such as microRNAs as biomarkers in neuropsychiatric disorders and the use of glucagon-like peptide-1 receptor agonists in alcohol use disorder. Contributions have appeared in Psychiatrist.com between 2025 and 2026. Frequent collaborators include Garima Yadav, Olu-Lawal Oluwanifesimi, Sadaf Khan, Sarah Waseem, and Zeeshan Mansuri.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
